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Jordan is an Arabic country of the Middle East. It has a
population growth rate of 2.3%; its population increased from 2.8
million in 1980 to 5.8million in 2008, with amale to female ratio of
1:1.The ﬁrst case of human immunodeﬁciency virus (HIV) in
Jordan was diagnosed in 1986. During the same year the National
AIDS Control Program (NAP) was established. This study presents a
ﬁrst analysis of 23 years of data from the NAP in Jordan (January
1986 to December 2008).
The NAP identiﬁes HIV cases from the central government
laboratory, which in Jordan is the only place to perform the
conﬁrmatoryWestern blot testing. The NAP also collects data from
screening programs on speciﬁc groups such as prisoners, patients
with tuberculosis, prostitutes (when possible), blood donors, and
certain employees upon the pre-employment check-up. The NAP
also offers medical care to patients and supervises the Voluntary
Counseling and Testing (VCT) centers. The VCT centers offer free
HIV testing, face-to-face, and over-the-phone counseling. The ﬁrst
center was established in Amman in 1999, then other centers
followed and there are currently 12 centers across Jordan. The NAP
has also offered free antiretroviral therapy since 1998.
A total of 194 cases in Jordanian citizens were reported to the
program during the study period. There were 155 males,
comprising 80% of cases. In all, 73% of cases acquired the infection
from outside Jordan, and 38% of HIV-infected individuals were
between the ages of 25 and 34 years comprising the most affected
age group. Figure 1 shows themodes of transmission. Amman, the
capital city, had the highest percentage of cases (59%), followed by
two other major cities, Irbid (14%) and Zarqa (12%). The overall[(Figure_1)TD$FIG]
Figure 1.Modes of transmission of HIV among Jordanian patients. HT, heterosexual;
MHSM, men having sex with men; IVD, intravenous drugs; PN, perinatal.
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doi:10.1016/j.ijid.2010.06.010mortality was 45%. Figure 2 shows the annual mortality and
prevalence of HIV cases.
Published data on HIV in Jordan are scarce. UNAIDS has
estimated the number of HIV cases in Jordan to be less than 2000.1
Published reports in our region have so far been available from two
nearby Arabic countries: Lebanon and Saudi Arabia.2–4 These
reports show several similarities to our results. Both showed a
preponderance of males and heterosexual contact as the most
commonmode of transmission. Both countries recognized the ﬁrst
cases of HIV in 1984. Moreover, the report from Saudi Arabia
described a low number of cases among the high-risk age group of
15–24 years and an overall high mortality rate (33%).4
Here, the preponderance of males could be due to travel abroad
and the practicing of unsafe sex. The observed low percentages in
the two groups of males having sex with males (2.5%) and
intravenous drug users (2.5%) is intriguing as one might expect
higher numbers. However, we believe that our numbers are very
close to the truth as we provide thorough counseling and have
noticed that patients do talk frankly to us about their risk
behaviors. Nevertheless, theremight be a slight underestimation in
the above two groups due to the associated heavy stigma.
The high number of cases in the larger cities could be due to the
high risk behaviors present in such large cities and to the
proportional effect of the large population size. Of interest here
is the high utilization of the VCT centers in Amman and Irbid,
which could have resulted in a higher detection in those areas.
Further activation of other centers will most probably increase the
detection rate, but still within limits proportional to the
corresponding population size. Finally, the high mortality rate
could partly be explained by delayed treatment or lack of
treatment, because prior to the provision of free antiretroviral
therapy by the NAP in 1998, most patients were unable to undergo
treatment due to the high cost of therapy in the private sector.
However, other factors such as delayed diagnosis and barriers from
either the patient, such as stigma, or from the system, such as cost,
difﬁculty in making appointments, or other barriers could also
have contributed to the high mortality rate, especially since the
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Figure 2. Annual mortality and number of both total and alive HIV cases.
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antiretroviral therapy in 1998.
In conclusion, Jordan appears to have a low number of HIV
cases. However, it should be noted that these numbers are not an
accurate reﬂection of HIV epidemiology since it is highly possible
that these ﬁgures were alternatively driven by factors stronger
than prevalence, such as illness, access, and desire for medical
healthcare. Therefore, efforts in combating the disease should
continue and large studies on high-risk populations should be
performed to determine the actual size of the epidemic.
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